We are live on ! Find out more
PFCS

Pale Fire Capital SE Portfolio holdings

AUM $1.14B
1-Year Est. Return 42.87%
This Fund
S&P 500
This Quarter Est. Return
+21.88%
1 Year Est. Return
+42.87%
3 Year Est. Return
+176.09%
5 Year Est. Return
10 Year Est. Return
AUM
$995M
AUM Growth
-$382M
Cap. Flow
-$492M
Cap. Flow %
-49.46%
Top 10 Hldgs %
87.93%
Holding
78
New
29
Increased
5
Reduced
12
Closed
4

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$6.41M
2
DAR icon
Darling Ingredients
DAR
+$3.04M
3
STNG icon
Scorpio Tankers
STNG
+$2.16M
4
TRIP icon
TripAdvisor
TRIP
+$2.12M
5
VIRT icon
Virtu Financial
VIRT
+$1.81M

Top Sells

Rank Stock Value
1
BP icon
BP
BP
+$103M
2
EXPE icon
Expedia Group
EXPE
+$8.83M
3
TALO icon
Talos Energy
TALO
+$7.92M
4
ARLO icon
Arlo Technologies
ARLO
+$4.47M
5
PPLI
People Inc
PPLI
+$3.37M

Sector Composition

Rank Sector Weight
1 Energy 70.44%
2 Communication Services 13.35%
3 Consumer Staples 9.22%
4 Industrials 4.07%
5 Consumer Discretionary 1.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRLD icon
51
Prelude Therapeutics
PRLD
$350M
$95.1K 0.01%
+30,781
New +$116K
CMRX
52
DELISTED
Chimerix, Inc.
CMRX
$94.9K 0.01%
+98,896
New +$108K
MNKD icon
53
CALL
MannKind Corp
MNKD
$1.18B
$94.2K 0.01%
+22,800
New +$102K
KURA icon
54
Kura Oncology
KURA
$812M
$91.7K 0.01%
+10,050
New +$102K
EWTX icon
55
Edgewise Therapeutics
EWTX
$4.11B
$89.6K 0.01%
+15,645
New +$106K
ACRS icon
56
Aclaris Therapeutics
ACRS
$767M
$89K 0.01%
+13,000
New +$111K
CMPX icon
57
Compass Therapeutics
CMPX
$335M
$89K 0.01%
+45,155
New +$112K
ATYR
58
aTyr Pharma
ATYR
$48.3M
$88.3K 0.01%
+55,857
New +$103K
ERAS icon
59
Erasca
ERAS
$6.2B
$82.9K 0.01%
+42,101
New +$108K
KZR
60
DELISTED
Kezar Life Sciences
KZR
$81.9K 0.01%
+6,885
New +$122K
TERN
61
DELISTED
Terns Pharmaceuticals
TERN
$76.5K 0.01%
+15,202
New +$96.5K
TNYA icon
62
Tenaya Therapeutics
TNYA
$160M
$71.7K 0.01%
+28,100
New +$118K
IOVA icon
63
Iovance Biotherapeutics
IOVA
$1.92B
$68.7K 0.01%
+15,100
New +$98.6K
PASG icon
64
Passage Bio
PASG
$15M
$64.9K 0.01%
4,933
NSTG
65
DELISTED
NanoString Technologies, Inc.
NSTG
$62.3K 0.01%
+36,200
New +$110K
RNW icon
66
ReNew
RNW
$2.29B
$54.3K 0.01%
+10,000
New +$59K
CDTX
67
DELISTED
Cidara Therapeutics
CDTX
$51.2K 0.01%
+2,718
New +$53.4K
LRMR icon
68
Larimar Therapeutics
LRMR
$416M
$47.6K ﹤0.01%
+12,040
New +$45.5K
TCRX icon
69
TScan Therapeutics
TCRX
$47.5M
$42.4K ﹤0.01%
+16,575
New +$38.7K
NGM
70
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$36.2K ﹤0.01%
+33,800
New +$69.9K
CCCC icon
71
C4 Therapeutics
CCCC
$386M
$35.7K ﹤0.01%
19,200
MRSN
72
DELISTED
Mersana Therapeutics
MRSN
$32.3K ﹤0.01%
1,016
BCAB icon
73
BioAtla
BCAB
$5.48M
$27K ﹤0.01%
318
GRTX
74
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$3.05K ﹤0.01%
+17,400
New +$21.6K
AGI icon
75
Alamos Gold
AGI
$12B
-138,581
Closed -$1.65M

Similar funds

Pale Fire Capital SE's Q3 2023 Portfolio in Review

As of Q3 2023, Pale Fire Capital SE held 78 positions worth $995M, down 28% from $1.38B the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Pale Fire Capital SE withdrew a net $492M in Q3 2023, closing 4 positions and reducing 12 holdings. Its most notable exit was Burford Capital, an estimated $2.13M position sold in full.

By sector, the portfolio is most concentrated in Energy at 70% of assets, up from 54% a quarter earlier, followed by Communication Services and Consumer Staples.

Against the trend, Pale Fire Capital SE opened a new position in Alibaba worth $6.07M.

  • Pale Fire Capital SE's largest Q3 2023 buy was Alibaba: 70,000 shares worth $6.07M.
  • Pale Fire Capital SE added most to Darling Ingredients in Q3 2023, an estimated $3.04M increase.
  • Pale Fire Capital SE's biggest Q3 2023 reduction was BP, cutting an estimated $103M.
  • Pale Fire Capital SE fully exited Burford Capital in Q3 2023, selling an estimated $2.13M.
  • Pale Fire Capital SE's ten largest holdings make up 88% of its $995M portfolio in Q3 2023.
  • Pale Fire Capital SE opened 29 new positions and closed 4 in Q3 2023.
  • Pale Fire Capital SE's portfolio value fell 28% quarter-over-quarter to $995M.

Based on Pale Fire Capital SE's 13F filing for Q3 2023, filed 13 Nov 2023.